Document is current
Any future updates will be listed below
-
Authors
Zhang, Tiantian
Shi, Lishuo
Jian, Liuying
Jiang, Jie
Qiu, Yijin
Xie, Feng
Zhang, Jianwei
Peng, Hui
Zhong, Lixing
Chen, Yexin
Zhong, Yunwu
Deng, Yanhong
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01211210 at ClinicalTrials.govnct01515787 at ClinicalTrials.govDocuments that mention this clinical trial
Neoadjuvant Modified Infusional Fluorouracil, Leucovorin, and Oxaliplatin With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Updated Results of the FOWARC Study After a Median Follow-Up of 10 Years
https://doi.org/10.1200/jco-24-01676
Clinical Benefit and Cost-Effectiveness of FOLFOX Versus LCCRT in Neoadjuvant Treatment for Patients with Locally Advanced Rectal Cancer: An Economic Analysis of the FOWARC and PROSPECT Trial
https://doi.org/10.1245/s10434-025-18802-8
Long-term outcome of neoadjuvant mFOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: A multicenter, randomized phase III trial.
https://doi.org/10.1200/jco.2023.41.16_suppl.3505
Documents that mention this clinical trial
Clinical Benefit and Cost-Effectiveness of FOLFOX Versus LCCRT in Neoadjuvant Treatment for Patients with Locally Advanced Rectal Cancer: An Economic Analysis of the FOWARC and PROSPECT Trial
https://doi.org/10.1245/s10434-025-18802-8
PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048).
https://doi.org/10.1200/jco.2023.41.17_suppl.lba2
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)
https://doi.org/10.1200/jco.23.00903
Individual tumor volume responses to short-course oxaliplatin-containing induction chemotherapy in locally advanced rectal cancer – Targeting the tumor for radiation sensitivity?
https://doi.org/10.1016/j.radonc.2016.02.020
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (72274079)
National Natural Science Foundation of China (8227102875)
Guangzhou Key Research and Development Program (202206080011)
National Key Clinical Discipline, and the program of Guangdong Provincial Clinical Research Center for Digestive Diseases (2020B1111170004)
- License Information
-
More Information
Article History
Received: 16 April 2025
Accepted: 15 November 2025
First Online: 11 December 2025
Disclosure
: The authors declare that they have no competing interests.
: This study was deemed exempt from review by the Sixth Affiliated Hospital, Sun Yat-sen University Review Board owing to the use of deidentified data.
: All authors have read and approved the final manuscript.
